S&P 500 7718.60 -0.38%
NASDAQ 26506.99 -0.29%
TASI 11024.73 -0.40%
Oil (WTI) 91.48 +0.00%
Oil (Brent) 96.28 +0.00%
VIX 15.30 +5.30%
Gold 4476.60 +0.00%
USD/SAR 3.76 +0.02%

Becton, Dickinson and Company

BDX · Healthcare · · USD
184.74 USD
0.00 (-1.54%)
● Updated 2026-09-07 21:04 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score BUY Short-term (Swing)

76
/ 100
Technical 75
Trend & RS 95
Momentum 76
Fundamental (0%) 63
Macro 64
Liquidity 46
ComponentScoreWeight
Technical 75.0 40%
Trend & RS 95.2 20%
Momentum 76.1 20%
Fundamental 62.8 0%
Macro 64.4 15%
Liquidity 45.7 5%

Trade Setup

Entry 184.74
Stop Loss 176.48 (4.5%)
Target 1 (1:1) 193.00 (+4.5%)
Target 2 (2:1) 201.26 (+8.9%)
ATR(14) 4.13 (2.2%)
Risk per Share 8.26
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 64.0 +0.56
Momentum 76.1 +1.04
Quality 24.0 -1.04
Composite 54.7

Quality Scores

Piotroski F-Score 6 /9 — Average
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score 2.95 Grey Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Fair Value

MetricStockSectorvs Peers
P/E Ratio 32.0 22.0 +45% above
P/B Ratio 2.1 4.0 Below
Dividend Yield 2.3% 1.5% Above avg

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value
82.57
vs
Market Price
184.74
Upside
-55.3%
Margin of Safety -123.7%
Stage 1 PV (5yr FCF)5,700,408,474
Terminal Value PV16,791,324,566
Total Enterprise Value22,491,733,040

Assumptions

Base FCF1,259,516,563
Growth Rate (5yr)5.4%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
49.37%
Full Kelly
24.69%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 76/100. Estimated win rate 63%, avg win 9.6%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

3
Bullish Signals
1
Bearish Signals
57.51
RSI(14)
5.0077
MACD

Relative Strength (RS) IMPROVING

87
/ 99
RS Rating
O'Neil PASS (≥80)
RS vs SPY ↑ RISING (+18.4% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (10d since high)
Sector Outperformance +15.3% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 57.51 NEUTRAL
Macd 5.0077 BEARISH
Ma Cross 170.0 / 158.61 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.88x NORMAL

Key Levels

LevelPrice
52-Week High193.07
Bollinger Upper193.54
SMA(200)158.61
SMA(50)170.0
SMA(20)186.18
Current Price184.74
Bollinger Lower178.82
52-Week Low127.59
ATR(14)4.13

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-08-31 Normal 1.61x Normal bar — no special VSA pattern
2026-09-01 Normal 0.79x Normal bar — no special VSA pattern
2026-09-02 Normal 0.91x Normal bar — no special VSA pattern
2026-09-03 Normal 0.74x Normal bar — no special VSA pattern
2026-09-04 Normal 0.88x Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 187.91 Above Kijun
Kijun-sen (26) 177.76 Base line
Senkou A 182.83 Leading span A
Senkou B 168.84 Leading span B
Cloud 168.84 – 182.83 Bullish (Green)
Price vs Cloud 184.74 Above Cloud
Chikou Span 165.62 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH FADING
BB: 178.82 – 193.54  |  KC: 180.1 – 192.25

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bearish MACD 11

Anchored VWAP

VWAP: 156.73 Anchor: 2025-11-06 (52w Low) ABOVE AVWAP +17.9%

Heikin-Ashi Trend

EXHAUSTION Trend exhaustion (3 doji candles) Full data via /api/advanced/BDX

Valuation

MetricValue
Market Cap50.32B
P/E (TTM)31.96
Forward P/EN/A
P/B2.06
EPS5.78

Financial Health

MetricValue
Revenue Growth5.4%
Profit Margin4.2%
ROE6.6%
Debt/Equity68.84
Current Ratio0.86
Dividend Yield2.3%
Payout RatioN/A
Beta0.28

Trading Data

184.74
Open
184.74
Day High
184.74
Day Low
1.44M
Volume (0.7x avg)

Recent News (8)

How Much Upside Can BSX Stock's Growth Deliver?
Trefis · 2026-09-04
How Is Becton, Dickinson and Company's Stock Performance Compared to Other Medical Devices Stocks?
Barchart · 2026-09-04
3 Dividend Stocks From a Value Pro
Barrons.com · 2026-09-04
Becton Dickinson (BDX) Becomes Founding Sponsor Of Hazardous Drug Data Consortium
Simply Wall St. · 2026-09-03
The Wide Divide Priced Into Boston Scientific Stock
Trefis · 2026-09-02
Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat
MT Newswires · 2026-09-01
The Peer-Group Mispricing Sitting On BSX Stock
Trefis · 2026-09-01
Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising Dividends
24/7 Wall St. · 2026-08-31

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —